EXPOSURE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: ANALYSIS FROM A MULTICENTER, RANDOMIZED CONTROLLED PIVOTAL TRIAL
Byong Duk Ye 1
Jaroslaw Leszczyszyn 2
Robert Dudkowiak 2
Adi Lahat 3
Beata Gawdis-Wojnarska 4
Aldis Pukitis 5
Marek Horynski
Katalin Farkas
Jaroslaw Kierkuś
Maciej Kowalski
Stefan Schreiber
Walter Reinisch
Sang Joon Lee
Sung Hyun Kim
Jee Hye Suh
Mi Rim Kim
Han Na Kim
Shomron Ben-Horin
1 University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea (Republic of)
2 Melita Medical,Wroclaw,Poland
3 Sheba Medical Center, Sackler School of Medicine, Tel Aviv University,Ramat Gan,Israel
4 Twoja Przychodnia - Szczecińskie Centrum Medyczne,Szczecin,Poland
5 Pauls Stradins Clinical Univers
Session
IBD Clinical III
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]